Aldeyra Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $23.8M | $83.4M | $77.9M |
| FY2021 | $27.4M | $233.1M | $229.8M |
| FY2022 | $30.3M | $181.3M | $144.4M |
| FY2023 | $28.5M | $148.3M | $142.8M |
| FY2024 | $33.6M | $104.6M | $54.5M |